Sharma East India Hospital & Medical Research Ltd: ₹32 Cr Sales and a 240% Negative OPM – The Jaipur Surgery Comedy
1. At a Glance
Sharma East India Hospital & Medical Research Ltd (SEIHMR) is a ₹43 Cr microcap running Jaipur Hospital, a NABH-accredited multispecialty hospital. On paper, it’s Rajasthan’s pride—first to do joint replacements, with futuristic “antistatic” operation theatres. On the balance sheet, it’s a mix of hospital bills, pharmacy sales, and accounting CPR. FY25 revenues jumped 65% to ₹32.6 Cr, profits grew 63% to ₹1.32 Cr, but margins wobble like a patient fresh out of anesthesia. The stock just doubled in 3 months (+45.8%)—making it the new “surgical strike” for penny-stock hunters.
2. Introduction
Hospitals are usually boring businesses—patients come in sick, leave poorer, and shareholders get their cut. But Sharma East India Hospital is different: it’s both a hospital and a real estate services company (yes, land + lungs under one roof).
Incorporated in 1989, the company is essentially Jaipur Hospital at Lal Kothi, Tonk Road, with ~100% revenue from patients and pharmacy. Empanelled with TPAs, govt. institutions, and banks, it gets a steady inflow of insured customers whose bills are processed faster than private patients’ recovery.
But financials reveal the irony: for 3 years ROE was negative (ouch), only turning positive in FY25 at 10.5%. The operating margin hovers around 11%, decent for a hospital, but the scale is tiny—₹32 Cr revenue is what Apollo Hospitals makes in less than two hours. Yet, being a microcap, even ₹1.3 Cr profit gives it a frothy P/E of 32.6×. Investors seem more excited about its growth spurt than its size, which is like cheering a toddler for taking two steps.
Special Sauce: Orthopedic replacement surgeries with shiny imported implants.
Facilities: Sterile OTs with “total body exhaust systems” (sounds like a fancy gym membership).
Revenue: ~100% from patient bills, pharmacy, and services—no diversification beyond healthcare.
Real Estate: Legacy business line, but not a meaningful contributor now.
Essentially, SEIHMR is a one-hospital, one-city operator. Investors betting here aren’t buying a chain—they’re buying a local hospital that hopes to scale up.
4. Financials Overview
Q1 FY26 Snapshot vs YoY & QoQ:
Metric
Jun 2025
Jun 2024
Mar 2025
YoY %
QoQ %
Revenue
₹9.47 Cr
₹6.72 Cr
₹5.98 Cr
+40.9%
+58.4%
EBITDA
₹0.92 Cr
₹0.86 Cr
₹0.81 Cr
+6.9%
+13.6%
PAT
₹0.32 Cr
₹0.25 Cr
₹0.37 Cr
+28.0%
-13.5%
EPS (₹)
~0.77
~0.60
~0.89
+28.3%
-13.5%
Commentary: Revenue jumped YoY and QoQ—hospital beds filled up. But PAT fell QoQ due to higher costs. Margins = fragile, like a glass syringe.
5. Valuation (Fair Value RANGE only)
Method 1: P/E
EPS (TTM) ≈ ₹4.0
Apply peer band (15–25× for small hospitals vs 50× for diagnostics giants).
